# Sartorius | Bioprocess Solutions

> Bioprocess technologies for biopharmaceuticals

Business model and tags: B2B, Has physical offices, Publicly traded, Manufacturing, Healthtech, Hardware, Multi-product, Sales-led purchase, Pharma & life sciences, Sells to enterprises, Multi-site, International operations, Has production sites, Has in-house R&D, Has a works council

## About Sartorius | Bioprocess Solutions

Provides technologies for separation, purification, concentration, storage, and transportation in biopharmaceutical manufacturing and process development.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Aubagne, Provence-Alpes-Côte d'Azur, France
- **Revenue**: €3B (FY2025, publicly reported)
- **SIREN**: [314093352](https://annuaire-entreprises.data.gouv.fr/entreprise/314093352)
- **Website**: [sartorius.com](http://www.sartorius.com)
- **LinkedIn**: [linkedin.com/company/sartorius-bioprocess-solutions](https://www.linkedin.com/company/sartorius-bioprocess-solutions)

## Sartorius | Bioprocess Solutions in the news

- [How Investors Are Reacting To Sartorius (XTRA:SRT3) Guidance Update](https://simplywall.st/stocks/de/pharmaceuticals-biotech/etr-srt3/sartorius-shares/news/how-investors-are-reacting-to-sartorius-xtrasrt3-guidance-up/amp) · simplywall.st · Nov 3, 2026
  Sartorius confirmed its 2026 guidance despite potential tariff and compensation impacts, is implementing a new operating model from 2027, and reported its latest sales and net income figures.
- [The Path to Autonomous Bioprocess Control](https://www.bioprocessintl.com/sponsored-content/the-path-to-autonomous-bioprocess-control) · bioprocessintl.com · Oct 27, 2026
  The article discusses the implementation of Autonomous Bioprocess Control (ABC) in the biopharmaceutical industry, highlighting challenges and a stepwise approach for its adoption.
- [Jefferies relève l’objectif de cours de Sartorius à 315 euros et maintient sa recommandation « Buy](https://www.zonebourse.com/actualite-bourse/jefferies-releve-la-objectif-de-cours-de-sartorius-a-315-euros-et-maintient-sa-recommandation-buy-ce785cdcd988f124) · zonebourse.com · Oct 26, 2026
  Jefferies increased Sartorius' price target to 315 euros and maintained its 'Buy' recommendation, citing strong Q3 results for Bioprocess Solutions and Lab Products & Services.

[See all 20 articles](https://www.tamtam.ai/c/sartorius-bioprocess-solutions/news)

## Sartorius | Bioprocess Solutions at a glance

Sartorius | Bioprocess Solutions is a B2B company in the Biotechnology Research industry, headquartered in Aubagne, Provence-Alpes-Côte d'Azur, France.

Sartorius | Bioprocess Solutions has 1,001–5,000 employees.

Sartorius | Bioprocess Solutions's revenue is €3B (FY2025, publicly reported).

Sartorius | Bioprocess Solutions's SIREN number is 314093352.

## Frequently asked questions about Sartorius | Bioprocess Solutions

### What is Sartorius | Bioprocess Solutions's revenue?

Sartorius | Bioprocess Solutions's revenue is €3B (FY2025, publicly reported).

### How many employees does Sartorius | Bioprocess Solutions have?

Sartorius | Bioprocess Solutions has 1,001–5,000 employees.

### Where is Sartorius | Bioprocess Solutions headquartered?

Sartorius | Bioprocess Solutions is headquartered in Aubagne, Provence-Alpes-Côte d'Azur, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/sartorius-bioprocess-solutions
